Table 2.
Clinical biochemical parameters
| Variables | Controls (42) | T2DMs (40) | P |
|---|---|---|---|
| TC (mmol/L) | 4.659 ± 0.12 | 4.808 ± 0.22 | .5506 |
| TG (mmol/L) | 1.547 ± 0.13 | 1.754 ± 0.21 | .4036 |
| LDL‐C (mmol/L) | 2.122 ± 0.09 | 2.551 ± 0.15 | .0142* |
| HDL‐C (mmol/L) | 1.274 ± 0.04 | 1.218 ± 0.06 | .4506 |
| FBG (mmol/L) | 4.703 ± 0.06 | 10.10 ± 1.33 | <.0001**** |
| FINS (μU/mL) | 8.573 ± 0.67 | 16.65 ± 2.09 | .0003*** |
| hsCRP (mg/L) | 3.292 ± 0.47 | 11.68 ± 0.81 | <.0001**** |
| GHb (%) | 7.277 ± 0.14 | 10.51 ± 0.43 | <.0001**** |
| HOMA‐IR | 1.799 ± 0.14 | 7.888 ± 1.74 | .0006*** |
Abbreviations: FBG, fasting blood glucose; FINS, fasting insulin; GHb, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; hsCRP, high sensitivity C‐reactive protein; LDL‐C, low‐density lipoprotein cholesterol; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TG, triglyceride.
*, ***, ****
Statistically significant between the T2DM and control groups.